These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27553208)

  • 1. Determinants of Change in the Cost-effectiveness Threshold.
    Paulden M; O'Mahony J; McCabe C
    Med Decis Making; 2017 Feb; 37(2):264-276. PubMed ID: 27553208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why Do Health Economists Promote Technology Adoption Rather Than the Search for Efficiency? A Proposal for a Change in Our Approach to Economic Evaluation in Health Care.
    Scotland G; Bryan S
    Med Decis Making; 2017 Feb; 37(2):139-147. PubMed ID: 27317437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis and innovation.
    Jena AB; Philipson TJ
    J Health Econ; 2008 Sep; 27(5):1224-36. PubMed ID: 18619695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic evaluation: what does a nurse manager need to know?
    Douglas HR; Normand C
    J Nurs Manag; 2005 Sep; 13(5):419-27. PubMed ID: 16108780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Societal Preferences for Interventions with the Same Efficiency: Assessment and Application to Decision Making.
    Shiroiwa T; Saito S; Shimozuma K; Kodama S; Noto S; Fukuda T
    Appl Health Econ Health Policy; 2016 Jun; 14(3):375-85. PubMed ID: 26940671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporating Affordability Concerns Within Cost-Effectiveness Analysis for Health Technology Assessment.
    Lomas JRS
    Value Health; 2019 Aug; 22(8):898-905. PubMed ID: 31426931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health Economics as Rhetoric: The Limited Impact of Health Economics on Funding Decisions in Four European Countries.
    Franken M; Heintz E; Gerber-Grote A; Raftery J
    Value Health; 2016 Dec; 19(8):951-956. PubMed ID: 27987645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health care rationing: doing it better in public and private health care systems.
    Maynard A
    J Health Polit Policy Law; 2013 Dec; 38(6):1103-27. PubMed ID: 23974472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incremental cost-effectiveness ratios (ICERs): the silence of the lambda.
    Gafni A; Birch S
    Soc Sci Med; 2006 May; 62(9):2091-100. PubMed ID: 16325975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Economic evaluation of medical therapy--methodological principles].
    Szucs TD; Schramm W
    Zentralbl Chir; 1995; 120(8):577-83. PubMed ID: 7571888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seeing the NICE side of cost-effectiveness analysis: a qualitative investigation of the use of CEA in NICE technology appraisals.
    Bryan S; Williams I; McIver S
    Health Econ; 2007 Feb; 16(2):179-93. PubMed ID: 16960851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the Estimation of the Cost-Effectiveness Threshold: Why, What, How?
    Vallejo-Torres L; García-Lorenzo B; Castilla I; Valcárcel-Nazco C; García-Pérez L; Linertová R; Polentinos-Castro E; Serrano-Aguilar P
    Value Health; 2016; 19(5):558-66. PubMed ID: 27565273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Health Economics Approach to US Value Assessment Frameworks-Summary and Recommendations of the ISPOR Special Task Force Report [7].
    Garrison LP; Neumann PJ; Willke RJ; Basu A; Danzon PM; Doshi JA; Drummond MF; Lakdawalla DN; Pauly MV; Phelps CE; Ramsey SD; Towse A; Weinstein MC
    Value Health; 2018 Feb; 21(2):161-165. PubMed ID: 29477394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporating Demand and Supply Constraints into Economic Evaluations in Low-Income and Middle-Income Countries.
    Vassall A; Mangham-Jefferies L; Gomez GB; Pitt C; Foster N
    Health Econ; 2016 Feb; 25 Suppl 1(Suppl Suppl 1):95-115. PubMed ID: 26786617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness in ambulatory care: alternative approaches.
    Angus DE; Auer L; Cloutier JE; Albert T
    J Ambul Care Manage; 1995 Jan; 18(1):29-38. PubMed ID: 10139344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formal Implementation of Cost-Effectiveness Evaluations in Japan: A Unique Health Technology Assessment System.
    Hasegawa M; Komoto S; Shiroiwa T; Fukuda T
    Value Health; 2020 Jan; 23(1):43-51. PubMed ID: 31952673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research.
    Woods B; Revill P; Sculpher M; Claxton K
    Value Health; 2016 Dec; 19(8):929-935. PubMed ID: 27987642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decision Making for Healthcare Resource Allocation: Joint v. Separate Decisions on Interacting Interventions.
    Dakin H; Gray A
    Med Decis Making; 2018 May; 38(4):476-486. PubMed ID: 29683792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Methods of comparative economic evaluations of therapies and for rational allocation of resources across sectors of health care systems - introduction, advantages, risks].
    Wasem J; Hessel F; Kerim-Sade C
    Psychiatr Prax; 2001 Jul; 28 Suppl 1():S12-20. PubMed ID: 11533902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can efficiency in health care be left to the market?
    Reinhardt UE
    J Health Polit Policy Law; 2001 Oct; 26(5):967-92. PubMed ID: 11765275
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.